PIPELINE OVERVIEW
|
PIPELINE
|
RECOTHROM®
OUTLICENSED PRODUCTS
|
CANDIDATE BACKGROUNDERS
PIPELINE OVERVIEW
ZymoGenetics' dedicated focus on the discovery and development of protein therapeutics has led to the following lead product candidates in clinical development:
Interleukin 21 (IL-21)
for the treatment of patients with cancer
PEG-Interferon lambda (IL-29)
for treatment of patients with hepatitis C
Pipeline information
Back to top
copyright © 2003 - 2008 ZymoGenetics
Back to top
